Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
17:44:58 EST Sun 08 Feb 2026
Enter Symbol
or Name
USA
CA



Isracann Biosciences Inc
Symbol IPOT
Shares Issued 175,228,944
Recent Sedar+ Documents

Isracann sees four directors, two officers resign

2024-01-22 18:54 ET - News Release

Subject: Isracann Biosciences Inc. - news release Word Document File: '\\swfile\EmailIn\20240122 154750 Attachment IPOT - Feb 14 - Press Release re Management Changes.docx' Isracann Biosciences Announces Management Changes VANCOUVER, BC, -- (January 22, 2024) - Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the "Company") announces that each of Sean Bromley, Yana Popova, Desmond Balakrishnan and George Vrabec have tendered their resignation as directors of the Company, and Yana Popova and Matthew Chatterton have tendered their resignation as officers of the Company, effective immediately. The Company thanks Messrs. Bromley, Balakrishnan, Vrabec and Chatterton, and Ms. Popova for their service to the Company and wishes them well in their future endeavors. ON BEHALF OF THE BOARD OF DIRECTORS "Ajay Singh Kaila" Ajay Singh Kaila Interim Chief Executive Officer About Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) Isracann is a multidisciplinary cannabis focused producer and product developer with Israeli-based cannabis production farm assets and a Canadian natural health medicine development and production arm. Concurrently focused on initial retail sales in Canada and in becoming a premier cannabis producer offering low-cost domestic Israeli production, the Company aims to commercialize natural health medicines in Canada and to leverage agreements within Israel for import/export opportunities and medicinal marijuana cultivation. For more information visit: w ww.isracann.com. Contact Empire Communications Group +1 (604) 343-2724 i nfo@isracann.com w ww.isracann.com Forward-Looking Information This release may contain forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects", "plans", "anticipates", "believes", "intends", "estimates", "projects", "potential" and similar expressions, or that events or conditions "will", "would", "may", "could" or "should" occur. Forward-looking statements may include, without limitation, statements relating to the Company's plans or goals, the Offering and the proceeds of the Offering. The forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. All forward-looking statements in this press release are made as of the date of this press release. The forward-looking statements contained herein are also subject generally to assumptions and risks and uncertainties that are described from time to time in the Company's documents filed from time to time with the Canadian Securities Exchange, the British Columbia Securities Commission, the Alberta Securities Commission, and the Ontario Securities Commission. Although Isracann believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in forward looking statements. Isracann expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise. The CSE does not accept responsibility for the adequacy or accuracy of this release.

© 2026 Canjex Publishing Ltd. All rights reserved.